Treatment of serious bleeds with an antihaemophilic factor VIII (recombinant), porcine sequence (OBI-1) in patients with acquired haemophilia A

被引：0
|
作者：
Kruse-Jarres, R. [1 ]
St-Louis, J. [2 ]
Greist, A. [3 ]
Shapiro, A. [3 ]
Smith, H. [4 ]
Chowdary, P. [5 ,6 ]
Drebes, A. [5 ,6 ]
Gomperts, E. [7 ]
Bourgeois, C. [8 ]
Mo, M. [9 ]
Novack, A. [9 ]
Farin, H. [9 ]
Ewenstein, B. [9 ]
机构：
[1] Tulane Univ, Sect Hematol Oncol, New Orleans, LA 70118 USA
[2] Univ Montreal, Div Hematol, Hop Maison Neuve Rosemont, Montreal, PQ, Canada
[3] Haemophilia & Thrombosis Ctr, Indianapolis, IN USA
[4] Tufts Univ New England Med Ctr, Div Hematol Oncol, Boson, MA USA
[5] Royal Free Hosp, Katharine Dormandy Haemophilia Ctr, London NW3 2QG, England
[6] Royal Free Hosp, Thrombosis Unit, London NW3 2QG, England
[7] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA
[8] Baxter BioSci, Vienna, Austria
[9] Baxter Healthcare, Westlake Village, CA USA
来源：
HAEMOPHILIA | 2015年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP081
引用
收藏
页码：62 / 62
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of OBI-1, an antihaemophilic factor VIII (recombinant), porcine sequence, in subjects with acquired haemophilia A
    Kruse-Jarres, R.
    St-Louis, J.
    Greist, A.
    Shapiro, A.
    Smith, H.
    Chowdary, P.
    Drebes, A.
    Gomperts, E.
    Bourgeois, C.
    Mo, M.
    Novack, A.
    Farin, H.
    Ewenstein, B.
    HAEMOPHILIA, 2015, 21 (02) : 162 - 170
  • [2] Recombinant porcine sequence factor VIII (OBI-1): Results from a prospective clinical study investigating the treatment of serious bleeds in patients with acquired hemophilia A
    Kruse-Jarres, R.
    St-Louis, J.
    Greist, A.
    Shapiro, A.
    Smith, H.
    Chowdary, P.
    Drebes, A.
    Gomperts, E.
    Chapman, M.
    Mo, M.
    Novack, A.
    Farin, H.
    HAEMOPHILIA, 2014, 20 : 1 - 1
  • [3] TREATMENT OF SERIOUS BLEEDS IN A PROSPECTIVE CLINICAL TRIAL WITH A B-DOMAIN DELETED RECOMBINANT PORCINE SEQUENCE FACTOR VIII (OBI-1) IN PATIENTS WITH ACQUIRED HEMOPHILIA A
    Kruse-Jarres, Rebecca
    St-Louis, Jean
    Greist, Anne
    Shapiro, Amy
    Smith, Hedy
    Chowdary, Pratima
    Drebes, Anja
    Gomperts, Edward
    Chapman, Miranda
    Mo, Min
    Novack, Aaron
    Farin, Heinrich
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (06) : E41 - E42
  • [4] Treatment Of Serious Bleeds With a B-Do Domain Deleted Recombinant Porcine Sequence Factor VIII (OBI-1) In Patients With Acquired Hemophilia A: A Prospective Clinical Trial
    Kruse-Jarres, Rebecca
    St Louis, Jean
    Greist, Anne
    Shapiro, Amy D.
    Smith, Hedy
    Chowdary, Pratima
    Drebes, Anja B.
    Gomperts, Edward D.
    Chapman, Miranda
    Mo, Min
    Novack, Aaron
    Farin, Heinrich D.
    BLOOD, 2013, 122 (21)
  • [5] Overview of the structure and manufacturing process for OBI-1, a recombinant porcine sequence, factor VIII for the treatment of acquired hemophilia A
    Wojciechowski, Peter
    Lai, Chee Kong
    Xiong, Yi
    Deer, Frank
    HAEMOPHILIA, 2014, 20 : 181 - 181
  • [6] The Benefit of FVIII Measurement: Tailored Treatment with Obi-1, a Recombinant Porcine Sequence Factor VIII, in Subjects with Acquired Hemophilia a
    Oladapo, Abiola
    Epstein, Joshua
    Novack, Aaron
    Farin, Heinrich D.
    BLOOD, 2014, 124 (21)
  • [7] The Effect of Inhibitory Antibodies on Acute Treatment of Bleeding Episodes with OBI-1, an Antihemophilic Factor VIII (recombinant), Porcine Sequence, in Patients with Acquired Hemophilia A
    Farin, Heinrich D.
    Novack, Aaron
    Mo, Min
    Bourgeois, Christelle
    Horling, Frank M.
    Ewenstein, Bruce M.
    BLOOD, 2014, 124 (21)
  • [8] Recombinant Porcine Factor VIII, Obi-1, Successfully Controlled Gastrointestinal Bleeding in a Patient with Acquired Hemophilia A
    Riaz, Muhammad Kashif
    Girnius, Saulius
    Palascak, Joseph Edward
    BLOOD, 2015, 126 (23)
  • [9] OBI-1, porcine recombinant Factor VIII for the potential treatment of patients with congenital hemophilia A and alloantibodies against human Factor VIII
    Toschi, Vincenzo
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2010, 12 (05) : 617 - 625
  • [10] Pharmacokinetics and safety of OBI-1, a recombinant B domain-deleted porcine factor VIII, in subjects with haemophilia A
    Kempton, C. L.
    Abshire, T. C.
    Deveras, R. A.
    Hoots, W. K.
    Gill, J. C.
    Kessler, C. M.
    Key, N. S.
    Konkle, B. A.
    Kuriakose, P.
    Macfarlane, D. E.
    Bergman, G.
    HAEMOPHILIA, 2012, 18 (05) : 798 - 804
12345